This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Thomas Jefferson University. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Eric Londin: Innovator in miRNA Research
Introduction
Eric Londin is a prominent inventor based in Philadelphia, PA (US). He has made significant contributions to the field of molecular biology, particularly in the area of microRNAs (miRNAs) and their applications in medical diagnostics and therapeutics. His innovative work has the potential to impact the diagnosis and treatment of various human conditions and diseases.
Latest Patents
Eric Londin holds a patent titled "Human miRNAs for use in diagnosis, prognosis, and therapy of human conditions and diseases." This patent discloses novel compositions, methods, and systems for determining whether a subject has, is at risk of developing, or is at a given stage of a condition afflicting a tissue of interest. The invention is based on the expression level of one or more novel miRNA and isomiR sequences. The described compositions and methods can be utilized to diagnose diseases or disorders, prognose stages of these conditions, and even develop treatments. In some embodiments, the novel miRNAs can serve as therapeutics for various diseases or disorders.
Career Highlights
Eric Londin is affiliated with Thomas Jefferson University, where he conducts his research and development work. His career is marked by a commitment to advancing the understanding of miRNAs and their roles in human health. With a focus on innovative solutions, he continues to explore the therapeutic potential of miRNAs.
Collaborations
Eric collaborates with notable colleagues, including Isidore Rigoutsos and Phillipe Loher. These partnerships enhance the research efforts and contribute to the advancement of knowledge in the field of miRNA applications.
Conclusion
Eric Londin's work in the field of miRNAs represents a significant advancement in medical research. His innovative patent and collaborations highlight his dedication to improving diagnostic and therapeutic strategies for human diseases. Through his contributions, he continues to pave the way for future innovations in healthcare.